Previous Article | Next Article 
Infection and Immunity, July 2001, p. 4398-4406, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4398-4406.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Growth Phase-Dependent Invasion of
Pseudomonas aeruginosa and Its Survival within HeLa
Cells
Unhwan
Ha and
Shouguang
Jin*
Department of Molecular Genetics and
Microbiology, University of Florida, Gainesville, Florida 32610
Received 12 October 2000/Returned for modification 25 January
2001/Accepted 21 March 2001
 |
ABSTRACT |
Clinical isolates of Pseudomonas aeruginosa are
classified into invasive and noninvasive (cytolytic) strains. In a
noninvasive PA103 background, ExoS and ExoT have recently been shown to
function as anti-internalization factors. However, these two factors
seemed not to have such a function in an invasive strain PAK
background. In this study, using HeLa tissue culture cells, we observed
that the internalization of invasive strain PAK is dependent on its growth phases, with the stationary-phase cells internalized about 100-fold more efficiently than the exponential-phase cells. This growth
phase-dependent internalization was not observed in the noninvasive
PA103 strain. Further analysis of various mutant derivatives of the
invasive PAK and the noninvasive PA103 strains demonstrated that ExoS
or ExoT that is injected into host cells by a type III secretion
machinery functions as an anti-internalization factor in both types of
strains. In correlation with the growth phase-dependent internalization, the invasive strain PAK translocates much higher amount of ExoS and ExoT into HeLa cells when it is in an
exponential-growth phase than when it is in a stationary-growth phase,
whereas the translocation of ExoT by the noninvasive strain PA103 is
consistently high regardless of the growth phases, suggesting a
difference in the regulatory mechanism of type III secretion between
the two types of strains. Consistent with the invasive phenotype of the
parent strain, an internalized PAK derivative survived well within the
HeLa cells, whereas the viability of internalized PA103 derivative was
dramatically decreased and completely cleared within 48 h. These
results indicate that the invasive strains of P. aeruginosa have evolved the mechanism of intracellular survival, whereas the
noninvasive P. aeruginosa strains have lost or not acquired the ability to survive within the epithelial cells.
 |
INTRODUCTION |
Pseudomonas aeruginosa is
an opportunistic human pathogen that infects severe-burn patients and
patients with leukemia, AIDS, cystic fibrosis, or cancer (2, 3,
28, 35). P. aeruginosa is capable of utilizing a wide
variety of carbon and nitrogen sources, enabling it to grow and persist
in diverse environments (26). P. aeruginosa is
armed with many virulence factors such as proteases, cytotoxins,
phospholipases, neuraminidase, capsular polysaccharides, and
lipopolysaccharides, contributing to its ability to colonize,
penetrate, and survive against host immune defense (9, 26,
35). Moreover, P. aeruginosa is intrinsically resistant and easily acquires resistance to antibiotics commonly used
to treat bacterial infections (23). Furthermore, its
ability to form biofilm enhances the bacterial resistance to various
antimicrobial agents (1, 6). These characteristics make it
difficult to avoid contamination by P. aeruginosa in the
hospital setting and hard to cure once patients are infected with
P. aeruginosa.
Clinical isolates of P. aeruginosa have been grouped into
invasive and noninvasive (cytolytic) strains based on their
interactions with nonphagocytic corneal epithelial cells
(12). The invasive and noninvasive strains encode
different sets of exoenzymes that are translocated into the host cells
via a type III secretion machinery (15, 37). The
noninvasive strains encode exoT and exoU genes,
whereas the invasive strains encode exoT and exoS genes (39). Although 49-kDa ExoS and 53-kDa ExoT share
75% identity at the amino acid level, ExoT was shown to possess only
0.2% of ADP-ribosyltransferase activity of the ExoS in an in vitro
assay (36). The ExoS preferentially ADP-ribosylates
several Ras family of GTP-binding proteins that regulate intracellular
vesicle transports, cell proliferations, and differentiations (4,
5). The ADP-ribosylating activity of the ExoS was also shown
recently to cause apoptosis in various tissue culture cells
(19). Both ExoS and ExoT also cause severe cell rounding
by disrupting actin cytoskeleton in an ADP-ribosyltransferase
activity-independent manner (16, 20, 27). Expressions of
these exoenzymes are coordinately regulated by a transcriptional
activator, ExsA, in response to various environmental signals,
including low calcium and direct contact with tissue culture cells
(11, 33, 36, 38).
P. aeruginosa strain PA103 is highly cytolytic and does not
invade epithelial cells (12). Its cytolytic activity
derives mainly from the function of the acute cytotoxin ExoU
(11). An exoU mutant of PA103 is still
noninvasive to the epithelial cells, indicating that the noninvasive is
not caused by its high cytotoxicity (10, 17). Recently,
ExoS and ExoT were reported to possess anti-internalization functions
in the cytolytic PA103 background (7). However, the
invasive P. aeruginosa strains are highly internalized into
the epithelial cells despite the presence of both ExoS and ExoT
(12). The mechanism for these differences has not been understood.
In this study, we demonstrate that the ExoS and ExoT function as
anti-internalization factors in both the invasive strain PAK and the
noninvasive strain PA103. We show that the internalization of invasive
PAK is dependent on its growth phases, which correlates with the growth
phase-dependent translocation of the ExoS and ExoT into HeLa cells. In
addition, the internalized invasive PAK derivative stably persisted in
the HeLa cells, whereas internalized noninvasive PA103 derivative was
killed quickly. The implication of these findings to the P. aeruginosa pathogenesis is also discussed.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
The bacterial strains and
plasmids used in this study are listed in Table
1. P. aeruginosa was grown in
Luria (L) agar or L broth at 37°C. Antibiotics were used at a final
concentration of 150 µg of carbenicillin, 200 µg of gentamicin, 200 µg of spectinomycin, 200 µg of streptomycin, and 100 µg of
tetracycline per ml for P. aeruginosa and 100 µg of
ampicillin, 5 µg of gentamicin, 50 µg of spectinomycin, 25 µg of
streptomycin, and 20 µg of tetracycline per ml for Escherichia
coli.
The exoS and exoT genes derived from PAK and
PA103 were cloned following amplified by PCR. The oligonucleotides used
to clone the exoS gene were exoS-1 (5'-CAG
TTG TTC GAG TTG ATG GTG GAT CTG GGC CCT GT-3') and
exoS-2 (5'-CGT TTC GTC GCC TGG ACC TAC CTC GAC AAG AAG
CA-3'). The oligonucleotides used to PCR clone the
exoT genes were exoT-1 (5'-AGG AAG GTC ATC
AGC AGG GCG ATC TCG GTG GTC AT-3') and exoT-2
(5'-GCT GTA CGG CGC AAA TGA AAA CGG ACA CCC CTT GG-3'). The
amplified DNA fragments were cloned into a PCR cloning vector,
pCR2.1-TOPO, and recloned into a broad-host-range vector, pUCP18, to be
transformed into P. aeruginosa. A 0.9-kb SmaI-KpnI fragment containing exoS
promoter of PAK and 1.1-kb NruI-KpnI fragments
containing exoT promoters of PAK and PA103 were fused to a
promoterless lacZ in pDN19lac
vector, resulting transcriptional fusion constructs of pHW0005, pHW0006, and pHW0018, respectively, to monitor corresponding gene expression.
Construction of ExoS-FLAG and ExoT-FLAG fusion plasmids.
The
exoS and exoT genes of PAK and PA103 were
amplified by PCR using primers that generate BglII sites at
3' ends which allowed in-frame fusions with the FLAG tag in C termini
by cloning into the BglII site (AGATCT) of
pFLAG-CTC. Oligonucleotides exoS-1 and exoS-4
(5'-TTA CGA CCG GTC ATG CCA GAT CTA AGG CCG CGC AT-3') were
used to amplify exoS, and oligonucleotides exoT-1
and exoT-4 (5'-CGG TCA GGC CAG ATC TGA GGC TGC GCA TTC
TCA GG-3') were used for exoT. PCR products were first
cloned into pCR2.1-TOPO, and then the inserts were reisolated as
EcoRI-BglII fragments for cloning into the
C-terminal FLAG tag fusion vector pFLAG-CTC. Resulting plasmids were
confirmed for in-frame fusions by sequencing and Western blot
using anti-FLAG monoclonal antibody. The exoS-FLAG and
exoT-FLAG clones were further isolated as
HindIII-SspI and HindIII-ScaI fragments, respectively, and
subcloned into the HindIII-SmaI sites of a
shuttle vector pUCP18 for use in P. aeruginosa.
-Galactosidase assay.
A standard
-galactosidase assay
(25) was conducted to determine the transcriptional
expression of exoS and exoT. For the HeLa cell
contact-mediated expressions, exponential- and stationary-phase P. aeruginosa cells were harvested and suspended in Dulbecco
modified Eagle medium (DMEM) containing 5% of fetal calf serum (FCS)
and 100 µg of tetracycline/ml. The suspensions were used to infect 4.0 × 105 of HeLa epithelial cells in six-well plates
at the indicated multiplicity of infection (MOI). At 2 h
postinfection at 37°C in 5% CO2, both surface-adhered
and lifted HeLa cells were washed three times with phosphate-buffered
saline (PBS) and treated with 0.25% of Trypsin-EDTA solution to
collect the adhered cells. The collected HeLa cells were suspended in Z
buffer (25) for the
-galactosidase assay as well as for
counting the number of viable bacterial cells by colony count.
Overnight cultures of P. aeruginosa in L broth containing
antibiotics was used as the stationary-phase bacterial cells, whereas
3-h subcultures of a 100-fold dilution of the stationary bacteria into
fresh L broth with antibiotics was used as the exponential-phase
bacterial cells.
Invasion assay.
A total of 4.0 × 105 HeLa
S3 epithelial cells in 3 ml of DMEM containing 5% FCS were seeded into
each of the six-well plates and incubated at 37°C in 5% of
CO2 for 24 h. After two washes with PBS, 1 ml of DMEM
containing 5% FCS was added to the HeLa cells, followed by the
addition of 0.1 ml of bacterial suspension in DMEM, giving rise to an
MOI of 10. The infected HeLa cells were incubated at 37°C in 5%
CO2 for 2 h. After three washes with PBS, the cells
were resuspended in 0.25% Triton-X100 and plated on L-agar plates
containing appropriate antibiotics to count the number of bacteria
associated with HeLa cells. To another set of the infected HeLa cells,
1 ml of DMEM containing 5% FCS and 400 µg of amikacin per ml was
added and incubated at 37°C in 5% CO2 for 2 h. The
cells were washed twice with PBS and lysed with 0.25% Triton X-100,
and the suspension was plated as described above. To test intracellular
survival, HeLa cells were infected with PAKexoSexoT mutant
at an MOI of 10 or PA103exoUexoT mutant at an MOI of 100. After 2 h of incubation at 37°C in 5% CO2, the HeLa
cells were washed and immersed in 2 ml of DMEM containing 5% FCS and
400 µg of amikacin per ml and then incubated at 37°C in 5%
CO2 for 2, 6, 12, 24, 36, 48, or 60 h. After two
washes with PBS, the infected HeLa cells were lysed with 0.25% Triton X-100 and plated on L-agar plates containing appropriate antibiotics in
order to count the number of bacterial cells.
Detection of ExoS and ExoT proteins translocated into HeLa
cells.
A total of 3.0 × 106 HeLa S3 epithelial
cells in 3 ml of DMEM containing 5% FCS were seeded in tissue culture
dishes (60 by 15 mm), and the HeLa cells were incubated at 37°C in
5% of CO2 for 24 h. After two washes with PBS, the
cells were immersed in 1 ml of DMEM containing 5% FCS, followed by
addition of a 0.1-ml bacterial suspension in DMEM, resulting in an MOI
of 10. The infected HeLa cells were incubated at 37°C in 5%
CO2 for 2 h. After three washes with PBS, the cells
were collected by cell scrapers and spun at 1,000 × g
for 5 min to pellet the HeLa cells. The HeLa cells were lysed with
0.25% Triton X-100 and spun at 13,000 rpm for 2 min. Pellets were
suspended in 1 ml of PBS and used to count the number of bacterial
cells by colony count. Proteins were precipitated from the supernatant
by the addition of trichloroacetic acid (TCA) to final concentration of
15%. After incubation at 4°C for 2 h, protein precipitates were
collected by spinning at 13,000 rpm for 5 min and washing with acetone.
The samples were suspended in 1× protein loading buffer for
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western
blot analysis.
Other methods.
Standard methods were used for plasmid DNA
preparation, restriction enzyme digestion, and cloning
(29). DNA sequence analysis was performed by PCR-mediated
Taq DyeDeoxy Terminator Cycle sequence using an Applied
Biosystems model 373A DNA sequencer. DNA restriction enzyme sites and
open reading frame analyses were conducted using the DNA Strider
program. Southern hybridizations were carried out using the enhanced
chemiluminescence (ECL) labeling and detection kit from Amersham. For
Western hybridizations, a monoclonal antibody against FLAG peptide from
Sigma and an anti-mouse immunoglobulin conjugated with horseradish
peroxidase were used with the ECL labeling and detection kit from Amersham.
 |
RESULTS |
Growth phase-dependent internalization of invasive strain PAK.
While studying apoptosis caused by invasive strains of P. aeruginosa, we observed that the growth phases of the bacterial cells seem to affect their ability to cause apoptosis as well as
invasion. To confirm the effect of bacterial growth phases on the
internalization of P. aeruginosa into HeLa cells, an
invasive strain PAK was grown in L broth to the exponential or
stationary phase and subjected to invasion assay by infecting HeLa
cells (see Materials and Methods). As shown in Fig.
1, PAK cells in stationary-growth phase
internalized into the HeLa cells about 100-fold more efficiently than
that in exponential phase, although bacterial binding abilities to HeLa
cells were the same. We tested if the stationary-phase-specific sigma
factor RpoS is required for the higher invasion rate of the
stationary-phase cells. Invasion test of the rpoS mutant
strain, PAKrpoS, showed a pattern of growth phase-dependent
internalization similar to that of the wild-type PAK, indicating that
RpoS is not required for the bacterial invasion. However, when a type
III null mutant strain PAKexsA was used in the invasion
assay, it was internalized at a high rate without being affected by its
growth phases, indicating that the low invasion rate seen with
exponential-phase cells is a type III secretion-dependent phenomenon.
Furthermore, the high invasion rate seen with stationary-phase cells is
independent of type III secretion.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
Growth phase-dependent internalizations of P. aeruginosa into HeLa epithelial cells. Exponential (E)- and
stationary (S)-phase bacterial cells were used to infect HeLa S3 cells
at an MOI of 10 and incubated at 37°C in 5% CO2 for
2 h. After three washes with PBS, the bacteria associated with the
HeLa cells were plated with serial dilutions for the colony count (open
bars). Another set of infected HeLa cells was incubated at 37°C in
5% CO2 for 2 h in the presence of amikacin to kill
extracellular bacteria, and the number of intracellular bacteria was
calculated from the colony count (solid bars). PAK, an invasive
wild-type strain; exsA, type III mutant strain PAKexsA;
rpoS, rpoS mutant strain PAKrpoS; fliC, flagellum
structural gene mutant strain PAKfliC; exoUT,
exoU and exoT double mutant of PA103,
PA103exoUexoT; exoU, exoU mutant of PA103,
PA103exoU; exoST, exoS and exoT double
mutant of PAK, PAKexoSexoT. Average values from three
repeated tests are shown.
|
|
An exoU mutant strain of PA103, PA103exoU,
internalized poorly in both the exponential- and the
stationary-growth phases, whereas an exoU exoT double
mutant, PA103exoUexoT, internalized at a high rate
regardless of the growth phases (Fig. 1). These results indicated that
the internalization of cytolytic PA103 is not affected by the growth
phases and that ExoT indeed functions as an anti-internalization factor
as reported previously (7). The binding capacity of the
PA103exoU to the HeLa cells was about 10-fold less than the
invasive PAK which is 10% of the input bacteria. This is likely due to
the fact that PA103 strain is a genuine nonmotile bacterium due to a
defect in flagella. Consistent with this prediction, a nonflagellated
mutant of PAK, PAKfliC, showed a level of decrease in
binding to the HeLa cells similar to that of PA103 (1% of input
bacteria), but its internalization rate remained the same as wild-type
PAK (10% of bound bacteria) (Fig. 1), indicating that a defect in the
flagella affects binding to the HeLa cells but does not affect the
growth phase-dependent internalization.
Anti-internalization functions of ExoS and ExoT.
The ExoS and
ExoT were shown to block the uptake of noninvasive P. aeruginosa PA103 into epithelial cells (7). However, the stationary-phase PAK is highly internalized into HeLa cells despite
the presence of both ExoS and ExoT. We determined whether the
anti-internalization functions of ExoS and ExoT derived from PAK differ
from ExoT of PA103. The exoS and exoT of PAK, as
well as exoT of PA103, were cloned and transformed into a
PA103exoUexoT double mutant background which is highly
invasive and encodes no exoenzymes. In addition, we also used
exoS (in pUCPexoS), exoSE381A (in
pUCPexoSE381A), and exoT (in pUCPexoT)
of 388 to compare the anti-internalization functions with the
exoenzymes of PAK. As shown in Fig. 2A,
PA103exoUexoT complemented with any of the exoS or exoT clones resulted in an almost 1,000-fold decrease in
the invasion rate compared to the mutant complemented with a vector. These results suggested that there is no significant difference in
anti-internalization activities among the three exoenzymes derived from
invasive and cytolytic strains; therefore, the high internalization of
invasive PAK in the stationary phase is not due to low
anti-internalization activities of its ExoS or ExoT. Furthermore, the
ADP-ribosylating activity is not required for the anti-internalization
activity of the ExoS.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 2.
Anti-internalization functions of ExoS and ExoT in a
PA103 background. Stationary-phase bacteria were used to infect HeLa S3
cells and incubated at 37°C in 5% CO2 for 2 h.
After three washes with PBS, the number of bacteria associated with the
HeLa cells were counted (open bars). Another set of the infected HeLa
cells was incubated at 37°C in 5% CO2 for 2 h in
the presence of amikacin to kill extracellular bacteria, and the number
of intracellular bacteria was counted (solid bars). (A)
Anti-internalization functions of ExoS and ExoT derived from PAK, 388, and PA103. exoUT, PA103exoUexoT double mutant; V, pUCP18
vector; pUCPexoS, encoding the exoS gene of
strain 388; pUCPexoSE381A, encoding the exoS gene
mutated at E381A; pUCPexoT, encoding the exoT
gene of strain 388; 0004, pHW0004 encoding the exoT gene of
PAK; 0015, pHW0015 encoding the exoS gene of PAK; 0017, pHW0017 encoding the exoT gene of PA103. (B) Interference
tests between ExoS and ExoT for their anti-internalization functions.
exoS, PAKexoS mutant; exoST, PAKexoSexoT double
mutant; exoU, PA103exoU mutant; exoUT,
PA103exoUexoT double mutant; V, pUCP18 vector; 0015, pHW0015
encoding exoS gene of PAK. Average values from three
repeated tests are shown.
|
|
Since the invasive strain PAK encodes both ExoS and ExoT, whereas PA103
encodes ExoT only, we next tested if the ExoS and ExoT interfere with
each other's anti-internalization function. To test this, we compared
the invasion rates of PAKexoS(pUCP18) that encodes only
exoT, PAKexoS(pHW0015) that encodes both
exoS and exoT, and
PAKexoSexoT(pHW0015) that encodes only exoS. As shown in Fig. 2B, these three mutant strains showed a growth
phase-dependent invasion phenotype similar to that of the wild-type
PAK, suggesting that there is no interference between ExoS and ExoT.
This is further supported by the observation that
PA103exoU(pHW0015), which encodes both
exoS and exoT, is as poorly invasive as
PA103exoU(pUCP18), which encodes exoT only,
and PA103exoUexoT(pHW0015), which encodes exoS
only. Thus, the high invasion rate of stationary-phase PAK is not due
to interference between the ExoS and ExoT. Interestingly, an
exoS and exoT double mutant of PAK,
PAKexoSexoT, showed a high invasion rate both in exponential
and in stationary phases (Fig. 1), suggesting that the ExoS and ExoT
are responsible for the low invasion rate of the exponential-phase
cells of invasive strain PAK.
Expression of the exoS and exoT genes in
exponential- and stationary-growth phases.
The
anti-internalization functions of the ExoS and ExoT are observed only
in exponential-phase cells of the invasive strain PAK, suggesting that
the expression of exoS and exoT might be regulated in a growth phase-dependent manner. To examine this, we
generated lacZ reporter gene fusions to exoS and
exoT promoters derived from PAK as well as exoT
promoter derived from PA103, i.e., pHW0005, pHW0006, and pHW0018,
respectively. The three fusion constructs were transformed into
PAKexoSexoT and PA103exoUexoT, as well as type
III mutant PAKexsA. The strains were cultured in L broth
containing appropriate antibiotics to exponential or stationary phase,
and the
-galactosidase activities were measured. As shown in
Fig. 3A, expression of the
exoS and exoT in a PAKexoSexoT and
PA103exoUexoT background was not significantly different in the two growth phases. As expected, no significant expression of
exoS and exoT was detected in PAKexsA
mutant in either of the two growth phases. These results indicated that
the growth phase-dependent internalization rate of the invasive PAK
strain is not caused by a difference in the expression of
exoS and exoT in L broth before subjecting it to
invasion assays.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 3.
Transcriptional activation of exoS and
exoT. (A) Growth phase-dependent expressions. Bacterial
strains were cultured in L broth containing appropriate antibiotics to
the exponential and stationary phases. The cultured bacterial cells
were subjected to a standard -galactosidase assay. The displayed
values are the fold increase of -galactosidase activity relative to
the expression of pDN19lac vector control. (B) Cell contact-mediated
expression. The exponential- and stationary-phase bacterial cells were
used to infect HeLa cells and incubated at 37°C in 5%
CO2 for 2 h. After three washes with PBS, bacteria
associated with the HeLa cells were counted and subjected to the
-galactosidase assay. The displayed values are the fold increase of
-galactosidase activity relative to that of the pDN19lac vector
control. exsA, type III mutant strain PAKexsA; exoST,
PAKexoSexoT double mutant; exoUT, PA103exoUexoT
double mutant; 0005, pHW0005 encoding the
exoS::lacZ fusion of PAK; 0006, pHW0006
encoding the exoT::lacZ fusion of PAK;
0018, pHW0018 encoding the exoT::lacZ
fusion of PA103. Average values from three repeated tests are shown.
|
|
Next, we tested if there is a difference in the cell contact-mediated
expression of the exoS and exoT. To avoid HeLa
cell lifting, PAKexoSexoT and PA103exoUexoT
containing either the exoS::lacZ or the
exoT::lacZ fusion construct were used.
Bacterial cells were grown in L broth to exponential or stationary
phase and used to infect HeLa cells in DMEM tissue culture medium
containing 5% FCS. After 2 h of incubation, the
-galactosidase
activities of the HeLa cell associated bacteria were measured. As shown
in Fig. 3B, the
-galactosidase activities of the exponential-phase PAKexoSexoT were sharply higher than those of the
stationary-phase cells, especially exoT, whose induction in
exponential-phase cells was more than sevenfold higher than that of
stationary-phase cells. However, in the PA103exoUexoT
background, cell contact-mediated expression of the exoT was
equally high in both the exponential- and the stationary-growth phases.
These results indicated that cell contact-mediated activation of
exoS and exoT expression is dependent on the
growth phases in invasive strain PAK but not in the cytolytic PA103,
implying a difference in regulatory mechanisms of the expression of the
exoenzymes between the two strains.
Translocation of ExoS and ExoT into HeLa cells during
infection.
As type III effector molecules, the ExoS and ExoT must
be translocated into the host cells to exert their functions. To trace the amount of ExoS and ExoT that were translocated into the HeLa cells,
plasmid constructs were generated in which C termini of the ExoS and
ExoT were tagged with the FLAG peptide. Plasmid constructs with
ExoS-FLAG and ExoT-FLAG of PAK, pHW0029 and pHW0027, respectively, were
introduced into PAKexoSexoT, whereas the ExoT-FLAG of PA103, pHW0028; was introduced into PA103exoUexoT. Resulting
strains were cultured in L broth to exponential or stationary phase and infected HeLa cells at an MOI of 10 for PAK derivatives and of 100 for
PA103 derivatives to obtain a similar number of bacterial cell binding
to each HeLa cell (see Materials and Methods). After 2 h of
incubation, the infected HeLa cells were then lysed with 0.25% Triton
X-100, cell debris and bacterial cells were removed by centrifugation,
and proteins in the supernatant were precipitated with TCA. The
precipitated protein samples were standardized with the number of
bacterial cells associated with the HeLa cells during the infection.
ExoS and ExoT in the precipitate, representing those translocated, were
detected by Western blot analysis using monoclonal antibody against the
FLAG tag.
As shown in Fig. 4, the exponential-phase
PAK cells translocated an ~9.2-fold-higher amount of ExoT and an
~3.4-fold-higher amount of ExoS into HeLa cells than the
stationary-phase PAK cells. However, the cytolytic PA103 did not show a
significant difference in the amounts of ExoT translocation between
exponential- and stationary-growth-phase cells. As a control, no
ExoS-FLAG or ExoT-FLAG translocation was detected when the HeLa cells
were infected with PAKexsA harboring the
exoS-FLAG or exoT-FLAG construct (data not shown). In addition, PAKexoSexoT harboring
pppB-FLAG fusion, a non-type III secreted cytoplasmic
protein, translocated no detectable amount of the PppB-FLAG (Fig. 4),
although a high amount of this protein was detected from the bacterial
lysate (data not shown). Together, these results indicated that the
ExoS and ExoT proteins detected in our assays were the results of
specific type III secretion into HeLa cells.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 4.
Growth phase-dependent translocation of ExoS and ExoT
into HeLa cells. The exponential (E)- and stationary (S)-phase
bacterial cells were used to infect HeLa S3 cells at an MOI of 10 and
incubated at 37°C in 5% CO2 for 2 h. After three
washes with PBS, the infected HeLa cells were collected and lysed with
0.25% Triton X-100. The insoluble pellet of the lysate was suspended
with PBS to count the number of associated bacteria. Proteins in the
supernatant of HeLa cell lysate were precipitated with TCA. The numbers
of bacterial cells associated with the HeLa cells were used to
standardize the amount of proteins subjected to Western blot analysis.
The intensities of the Western blot bands were scanned by densitometer,
and the resulting values are shown in the bar figure. exoST,
PAKexoSexoT double mutant; exoUT, PA103exoUexoT
double mutant; 0027, pHW0027 encoding the exoT-FLAG fusion
of PAK; 0028, pHW0028 encoding the exoT-FLAG fusion of
PA103; 0029, pHW0029 encoding the exoS-FLAG fusion of PAK;
pppB, encoding the pppB-FLAG fusion of PAK.
|
|
The injection of both ExoS and ExoT is known to disrupt host cell
cytoskeletal structures causing HeLa cell morphological changes (cell
rounding). Correlating with the growth phase-dependent secretion of
ExoS and ExoT, the rates of HeLa cell rounding were also dependent on
the growth phases of the infecting bacterium. As shown in Fig.
5, after 80 min of incubation,
exponential- and stationary-phase PAK cells caused 60 and 20% HeLa
cell rounding, respectively, whereas PAKexsA and
PAKexoSexoT mutants did not cause significant cell rounding
at either growth phase (data not shown). However, independent of growth
phases, PA103exoU caused 60% cell rounding, whereas
PA103exoUexoT did not cause any cell rounding (data not
shown). These results clearly indicated that the exponential-phase PAK
cells translocate more efficiently than the stationary-phase cells both
the ExoS and the ExoT proteins into HeLa cells, and the higher amounts
of translocated ExoS and ExoT proteins inhibit the uptake of PAK cells,
resulting in a growth phase-dependent invasion phenotype.

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 5.
Morphological changes of HeLa cells infected with
P. aeruginosa. Exponential- and stationary-phase bacterial
cells were used to infect HeLa S3 cells that were cultured on cover
glasses. After incubation at 37°C in 5% CO2 for the
indicated length of times, the HeLa cells on the cover glasses were
observed under a light microscope. (A) No infection as a control. (B)
HeLa cells infected with exponential-phase of PAK. (C) HeLa cells
infected with stationary-phase PAK. (D) HeLa cells infected with
exponential-phase PA103exoU mutant. (E) HeLa cells infected
with stationary-phase PA103exoU mutant.
|
|
Intracellular survival of invasive and noninvasive P. aeruginosa strains.
Since mammalian cells can effectively
clear most intracellular bacteria, invasive bacterial pathogens are
usually equipped with factors that enable them to evade the
bactericidal effect of the host cells. We tested whether the invasive
strain PAK is also equipped with such a factor. To compare the
intracellular survival of invasive strain PAK and noninvasive strain
PA103, corresponding mutant strains PAKexoSexoT and
PA103exoUexoT were used to avoid cytotoxicity and cell
lifting. HeLa cells were infected with each mutant for 2 h,
followed by amikacin treatment to kill extracellular bacteria. To
achieve the same number of bacteria bound to the HeLa cells, a 10-fold
higher MOI was used for PA103exoUexoT than for
PAKexoSexoT. HeLa cells were lysed at various time
points and plated to count the intracellular bacteria. As
shown in Fig. 6, PAKexoSexoT
maintained high viability inside HeLa cells by 60 h, the longest
time point followed, whereas the viability of PA103exoUexoT
decreased dramatically after 4 h of amikacin treatment and cleared
completely by 48 h. Similar results have been obtained when the
HeLa cells were infected with a 1:10 mixture of PAKexoSexoT and PA103exoUexoT (Fig. 6). The mixed infection exposed both
mutants to the same intracellular environment, allowing us to
accurately compare the relative survival abilities of the two mutant
strains. Furthermore, the MIC of amikacin for both strains was
identical (20 µg/ml), indicating that the observed decrease in
intracellular survival of PA103exoUexoT was not caused by a
higher sensitivity to the amikacin. These results demonstrate that the
invasive PAK strain has evolved an intracellular survival mechanism,
whereas the noninvasive PA103 strain lost or has not acquired such
ability.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Intracellular survival of P. aeruginosa
strains in HeLa cells. Stationary-phase bacteria were used to infect
HeLa S3 cells, and the infected HeLa cells were incubated at 37°C in
5% CO2 for 2 h. After three washes with PBS, the HeLa
cells were incubated at 37°C in 5% CO2 for 2, 6, 12, 24, 36, 48, and 60 h in the presence of 400 µg of amikacin per ml to
kill extracellular bacteria. The number of intracellular bacterial
cells was calculated by colony count. Symbols: ,
PAKexoSexoT double mutant; , PA103exoUexoT
double mutant; , PAKexoSexoT double mutant in the
mixed infections; , PA103exoUexoT double mutant in the
mixed infections. Average values of three repeated tests are shown.
|
|
 |
DISCUSSION |
The growth phase-dependent variation of invasion could be the
result of an increased expression of invasin during the stationary phase or an increased expression of anti-internalization factor during
the exponential phase. The fact that a type III mutant strain
PAKexsA is highly invasive in both exponential and
stationary phases suggested the latter is the case. Although both ExoS
and ExoT were shown to act as anti-internalization factors in a
cytolytic strain background (7), it was not clear why
exoS and exoT harboring invasive strains are
highly invasive (12). In this study, we first demonstrated
that there is no significant difference in the anti-internalization
activities of the ExoS and ExoT derived from the two types of strains.
Then, we showed that there is no interference of the
anti-internalization functions between ExoS and ExoT, as P. aeruginosa has been known to produce a heterologous aggregate of
ExoS and ExoT (33). Finally, the growth phase-dependent invasion phenotype was correlated to the differential expression of the
exoS and exoT during the exponential phase versus
the stationary phase in response to HeLa cell contact. This
cause-and-effect relationship was confirmed by demonstrating that the
ExoS and ExoT do function as anti-internalization factors in both
invasive and noninvasive strains, although the anti-internalization
phenotype is only observable in exponential-phase cells of the invasive strain. Another possibility existed in which the stationary-phase cells
of invasive PAK might synthesize a specific inhibitor that interrupts
the anti-internalization functions of the ExoS and ExoT. The inhibitor
molecule could be secreted directly into the host cells or localized on
the surface of bacterial cells which interrupts host cell signal
transduction through direct interaction. This possibility was addressed
by a mixed infection of PAKexoSexoT as the source of the
possible inhibitor and PA103exoU as the source of
anti-internalization factor ExoT. The anti-internalization function of
ExoT from PA103exoU was not affected by the presence of
PAKexoSexoT, resulting in low invasion of both strains (data not shown). This result indicated that PAK has no inhibitor that blocks
anti-internalization functions of the ExoS and ExoT.
ExoS and ExoT are highly homologous, and both have two domain
structures, with N-terminal domains having GAP (GTPase-activating protein) activities that cause disruptions in cytoskeletal structures and C-terminal domains with ADP-ribosylation activities (16, 18,
20, 27). The ADP-ribosylating activity of ExoT is only 0.2%
that of ExoS (36), although both molecules showed similar levels of anti-invasion activity; thus, it is unlikely that this activity is directly linked to the anti-internalization function. Also,
the experimental result with the ExoS(E381A) mutant which is defective
in ADP-ribosylating activity further supported the notion that the
N-terminal domains play the anti-internalization roles
(7). This is consistent with the observation that ExoS, ExoT, and ExoS(E381A) caused morphological changes without causing obvious membrane damages, indicating that actin microfilaments are
important for epithelial cells to take up P. aeruginosa
(13, 33). Thus, cytoskeletal disrupting functions of the
ExoS and ExoT are likely responsible for the inhibition of bacterial internalization.
Expressions of type III secretion components, including ExoS and ExoT,
are known to be stimulated by the depletion of divalent cations with
the treatment of EGTA or nitrilotriacetic acid, as well as contact with
mammalian cells (31). However, differences have been
observed between these two inducing conditions. Addition of 5 mM EGTA
induced significant levels of exoS-lacZ and
exoT-lacZ expression only after 4 h, whereas a 2-h
treatment had minimal effect. However, a 2-h incubation with HeLa cells
resulted in significant levels of both ExoS and ExoT expression, in
comparison to incubation with tissue culture medium without HeLa cells,
indicating that there is a difference in the ExsA-regulated genes
responding to the low-calcium conditions versus contact with eukaryotic
cells. Since the growth phase-dependent invasion was detected as early as 2 h postinfection, all of the assays were conducted after a 2-h
treatment (13). Our results of growth phase-dependent
invasion indicated that the exponential-phase PAK is much more
sensitive to cell contact signals than the stationary-phase cells,
whereas the PA103 responds equally well to the cell contact signal in the two growth phases.
Correlating to the cell contact-mediated activation of gene expression,
translocation of the ExoS and ExoT into the host cell followed the same
pattern. Exponential-phase PAK translocated a 9.2-fold-higher amount of
ExoT and a 3.4-fold-higher amount of ExoS into the HeLa cells than did
stationary-phase PAK, whereas the amount of ExoT translocated by the
two growth-phase PA103 cells were not significantly different.
Therefore, the increased secretion of exoenzymes by the
exponential-phase cells could efficiently block the internalization of
bacteria into HeLa cells and cause faster cell rounding than by the
stationary phase of PAK. These results suggested that there is a
difference in the signal sensing and regulation of type III component
between the two strains. A similar observation was also made by Dacheux
et al. (8), who found that an invasive strain of P. aeruginosa CHA caused the most rapid cell death when it was in the
late-exponential-growth phase, whereas the bacterial cytotoxicity
dramatically decreased as soon as the bacterial growth phase entered
the stationary phase.
From the evolutionary point of view, the invasive PAK might be adapted
to the environments of mammalian cells and better able to survive
intracellularly than the cytotoxic PA103. To compare the intracellular
survival of invasive versus cytolytic strains, we have used
PAKexoSexoT and PA103exoUexoT, both of which are highly invasive and do not possess major host cell disrupting exoenzymes. Exposure of mammalian cells to ExoS and ExoU leads to cell
death through apoptosis and necrosis, respectively, whereas ExoT alters
the actin cytoskeleton typically by activating Rho-GTPase proteins
(20). Our data clearly indicated that the invasive strain
PAK has a mechanism to avoid intracellular killing and maintains its
viability, whereas the cytolytic strain PA103 has no such defense and
is cleared quickly. A similar observation has also been made for a
closely related strain of Burkholderia cepacia, for which it
was shown that clinical isolates are able to survive intracellularly in
both cultured macrophage and epithelial cells, whereas environmental
isolates are defective in this ability (24). The high
internalization rate and stable persistence inside host cells could
contribute to bacterial ability to evade host immune defense and the
efficient dissemination into deeper organs tissues.
Based on the growth phase-dependent invasion of PAK, invasive strains
may have two kinds of lifestyles depending on the environmental condition. During the stationary phase, typically under harsh growth
conditions such as nutrient depletion and increasing host immune
attacks, PAK becomes invasive by turning down ExoS and ExoT secretion
and escapes inside host cells, where it can persist for a long period
of time, whereas during exponential-growth phase under a high nutrient
growth environment there is no need to invade host cells; thus, PAK
acts more like a cytolytic strain by increasing the expression and
secretion of ExoS and ExoT in response to the cell contact, inhibiting
internalization into the host cells. In contrast to the invasive PAK,
regardless of the growth phases, the cytolytic strain PA103 blocks its
uptake into the cells and kills through the action of ExoU. These
hypotheses would predict that cytolytic strains are more likely
associated with acute and localized tissue necrosis, whereas invasive
strains are more likely associated with chronic and systemic infections.
The observation that a noninvasive strain PA103exoU can be
converted into an invasive strain by mutating the anti-internalization factor exoT indicated that the noninvasive strain naturally
encodes an invasin. Since the type III gene clusters are acquired by
bacterial pathogens through horizontal gene transfers, it is therefore
likely that strain PA103 is derived from an invasive ancestor by
acquiring the anti-invasion factor. Furthermore, despite the fact that
the noninvasive strain PA103 has lost or did not acquire genes for intracellular survival, it retained the invasin molecule, suggesting that the invasin is likely to have additional function that is essential or that renders the bacterium a survival advantage. In
support of this view, the invasin gene seems to be constitutively expressed in both types of strains since PAKexoSexoT and
PA103exoUexoT are highly invasive regardless of growth
phases. A recent study by Fleiszig's group has shown that mutation in
a key component required for flagellum assembly, flhA,
drastically reduces bacterial invasion (C. van Delden, S. K. Aurora, R. Ramphal, and M. J. Fleiszig, Abstr. 100th Gen. Meet.
Am. Soc. Microbiol. 2000, abstr. D-145, 2000). Since the FlhA is an
inner membrane protein and is commonly present among flagellated
bacterium, the finding implies that the translocation of the
"invasin" to the bacterial cell surface or secretion into the host
cell requires this component. The real invasin molecule has yet to be identified.
 |
ACKNOWLEDGMENTS |
We thank members of S. Jin's laboratory for helpful discussion
and suggestions.
This work was supported by NIH grant R29AI39524.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, P.O. Box 100266, University of
Florida, Gainesville, FL 32610-0266. Phone: (352) 392-8323. Fax: (352) 392-3133. E-mail: sjin{at}mgm.ufl.edu.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Anwar, H.,
J. L. Strap, and J. W. Costerton.
1992.
Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy.
Antimicrob. Agents Chemother.
36:1347-1351[Free Full Text].
|
| 2.
|
Asboe, D.,
V. Gant,
H. M. Aucken,
D. A. Moore,
S. Umasankar,
J. S. Bingham,
M. E. Kaufmann, and T. L. Pitt.
1998.
Persistence of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients.
AIDS
12:1771-1775[Medline].
|
| 3.
|
Bodey, G. P.,
R. Bolivar,
V. Fainstein, and L. Jadeja.
1983.
Infections caused by Pseudomonas aeruginosa.
Rev. Infect. Dis.
5:279-313[Medline].
|
| 4.
|
Bourne, H. R.,
D. A. Sanders, and F. McCormick.
1990.
The GTPase superfamily: a conserved switch for diverse cell functions.
Nature
348:125-132[CrossRef][Medline].
|
| 5.
|
Coburn, J., and D. M. Gill.
1991.
ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.
Infect. Immun.
59:4259-4262[Abstract/Free Full Text].
|
| 6.
|
Costerton, J. W.,
P. S. Stewart, and E. P. Greenberg.
1999.
Bacterial biofilms: a common cause of persistent infections.
Science
284:1318-1322[Abstract/Free Full Text].
|
| 7.
|
Cowell, B. A.,
D. Y. Chen,
D. W. Frank,
A. J. Vallis, and S. M. Fleiszig.
2000.
ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells.
Infect. Immun.
68:403-406[Abstract/Free Full Text].
|
| 8.
|
Dacheux, D.,
B. Toussaint,
M. Richard,
G. Brochier,
J. Croize, and I. Attree.
2000.
Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.
Infect. Immun.
68:2916-2924[Abstract/Free Full Text].
|
| 9.
|
Doring, G.,
M. Maier,
E. Muller,
Z. Bibi,
B. Tummler, and A. Kharazmi.
1987.
Virulence factors of Pseudomonas aeruginosa.
Antibiot. Chemother.
39:136-148[Medline].
|
| 10.
|
Evans, D. J.,
D. W. Frank,
V. Finck-Barbancon,
C. Wu, and S. M. Fleiszig.
1998.
Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity.
Infect. Immun.
66:1453-1459[Abstract/Free Full Text].
|
| 11.
|
Finck-Barbancon, V.,
J. Goranson,
L. Zhu,
T. Sawa,
J. P. Wiener-Kronish,
S. M. Fleiszig,
C. Wu,
L. Mende-Mueller, and D. W. Frank.
1997.
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Mol. Microbiol.
25:547-557[CrossRef][Medline].
|
| 12.
|
Fleiszig, S. M.,
J. P. Wiener-Kronish,
H. Miyazaki,
V. Vallas,
K. E. Mostov,
D. Kanada,
T. Sawa,
T. S. Yen, and D. W. Frank.
1997.
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S.
Infect. Immun.
65:579-586[Abstract].
|
| 13.
|
Fleiszig, S. M.,
T. S. Zaidi, and G. B. Pier.
1995.
Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro.
Infect. Immun.
63:4072-4077[Abstract].
|
| 14.
|
Frank, D. W.,
G. Nair, and H. P. Schweizer.
1994.
Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.
Infect. Immun.
62:554-563[Abstract/Free Full Text].
|
| 15.
|
Frithz-Lindsten, E.,
Y. Du,
R. Rosqvist, and A. Forsberg.
1997.
Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
Mol. Microbiol.
25:1125-1139[CrossRef][Medline].
|
| 16.
|
Goehring, U. M.,
G. Schmidt,
K. J. Pederson,
K. Aktories, and J. T. Barbieri.
1999.
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
J. Biol. Chem.
274:36369-36372[Abstract/Free Full Text].
|
| 17.
|
Hauser, A. R.,
S. Fleiszig,
P. J. Kang,
K. Mostov, and J. N. Engel.
1998.
Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells.
Infect. Immun.
66:1413-1420[Abstract/Free Full Text].
|
| 18.
|
Iglewski, B. H.,
J. Sadoff,
M. J. Bjorn, and E. S. Maxwell.
1978.
Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.
Proc. Natl. Acad. Sci. USA
75:3211-3215[Abstract/Free Full Text].
|
| 19.
|
Kaufman, M. R.,
J. Jia,
L. Zeng,
U. Ha,
M. Chow, and S. Jin.
2000.
Pseudomonas aeruginosa mediated apoptosis requires ADP-ribosylating activity of ExoS.
Microbiology
146:2531-2541[Abstract/Free Full Text].
|
| 20.
|
Krall, R.,
G. Schmidt,
K. Aktories, and J. T. Barbieri.
2000.
Pseudomonas aeruginosa ExoT is a rho GTPase-activating protein.
Immun. Infect.
68:6066-6068[Abstract/Free Full Text].
|
| 21.
|
Kulich, S. M.,
D. W. Frank, and J. T. Barbieri.
1995.
Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.
Infect. Immun.
63:1-8[Abstract].
|
| 22.
|
Liu, P. V.
1966.
The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. III. Identity of the lethal toxins produced in vitro and in vivo.
J. Infect. Dis.
116:481-489[Medline].
|
| 23.
|
Lory, S., and P. C. Tai.
1985.
Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
Curr. Top. Microbiol. Immunol.
118:53-69[Medline].
|
| 24.
|
Martin, D. W., and C. D. Mohr.
2000.
Invasion and intracellular survival of Burkholderia cepacia.
Infect. Immun.
68:24-29[Abstract/Free Full Text]. (Erratum, 68:3792.)
|
| 25.
|
Miller, J. H.
1972.
Experiments in molecular genetics.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 26.
|
Nicas, T. I., and B. H. Iglewski.
1985.
The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
Can. J. Microbiol.
31:387-392[Medline].
|
| 27.
|
Pederson, K. J.,
A. J. Vallis,
K. Aktories,
D. W. Frank, and J. T. Barbieri.
1999.
The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
Mol. Microbiol.
32:393-401[CrossRef][Medline].
|
| 28.
|
Roilides, E.,
K. M. Butler,
R. N. Husson,
B. U. Mueller,
L. L. Lewis, and P. A. Pizzo.
1992.
Pseudomonas infections in children with human immunodeficiency virus infection.
Pediatr. Infect. Dis. J.
11:547-553[Medline].
|
| 29.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory mannual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 30.
|
Schweizer, H. P.
1991.
Escherichia-Pseudomonas shuttle vectors derived from pUC18/19.
Gene
97:109-112[CrossRef][Medline].
|
| 31.
|
Thompson, M. R.,
M. J. Bjorn,
P. A. Sokol,
J. D. Lile, and B. H. Iglewski.
1980.
Exoenzyme S: an ADP-ribosyl transferase produced by Pseudomonas aeruginosa, p. 425-433.
In
M. Smulson, and T. Sugimura (ed.), Novel ADP-ribosylations of regulatory enzymes and proteins. Elsevier North-Holland, Inc., Amsterdam, The Netherlands.
|
| 32.
|
Totten, P. A., and S. Lory.
1990.
Characterization of the type a flagellin gene from Pseudomonas aeruginosa PAK.
J. Bacteriol.
172:7188-7199[Abstract/Free Full Text].
|
| 33.
|
Vallis, A. J.,
V. Finck-Barbancon,
T. L. Yahr, and D. W. Frank.
1999.
Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.
Infect. Immun.
67:2040-2044[Abstract/Free Full Text].
|
| 34.
|
Vallis, A. J.,
T. L. Yahr,
J. T. Barbieri, and D. W. Frank.
1999.
Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions.
Infect. Immun.
67:914-920[Abstract/Free Full Text].
|
| 35.
|
Van Delden, C., and B. H. Iglewski.
1998.
Cell-to-cell signaling and Pseudomonas aeruginosa infections.
Emerg. Infect. Dis.
4:551-560[Medline].
|
| 36.
|
Yahr, T. L.,
J. T. Barbieri, and D. W. Frank.
1996.
Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
J. Bacteriol.
178:1412-1419[Abstract/Free Full Text].
|
| 37.
|
Yahr, T. L.,
J. Goranson, and D. W. Frank.
1996.
Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway.
Mol. Microbiol.
22:991-1003[CrossRef][Medline].
|
| 38.
|
Yahr, T. L.,
A. K. Hovey,
S. M. Kulich, and D. W. Frank.
1995.
Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene.
J. Bacteriol.
177:1169-1178[Abstract/Free Full Text].
|
| 39.
|
Yahr, T. L.,
L. M. Mende-Mueller,
M. B. Friese, and D. W. Frank.
1997.
Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon.
J. Bacteriol.
179:7165-7168[Abstract/Free Full Text].
|
Infection and Immunity, July 2001, p. 4398-4406, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4398-4406.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shen, D.-K., Filopon, D., Chaker, H., Boullanger, S., Derouazi, M., Polack, B., Toussaint, B.
(2008). High-cell-density regulation of the Pseudomonas aeruginosa type III secretion system: implications for tryptophan catabolites. Microbiology
154: 2195-2208
[Abstract]
[Full Text]
-
Yang, H., Shan, Z., Kim, J., Wu, W., Lian, W., Zeng, L., Xing, L., Jin, S.
(2007). Regulatory Role of PopN and Its Interacting Partners in Type III Secretion of Pseudomonas aeruginosa. J. Bacteriol.
189: 2599-2609
[Abstract]
[Full Text]
-
Rodrigues, F., Sarkar-Tyson, M., Harding, S. V., Sim, S. H., Chua, H. H., Lin, C. H., Han, X., Karuturi, R. K. M., Sung, K., Yu, K., Chen, W., Atkins, T. P., Titball, R. W., Tan, P.
(2006). Global Map of Growth-Regulated Gene Expression in Burkholderia pseudomallei, the Causative Agent of Melioidosis. J. Bacteriol.
188: 8178-8188
[Abstract]
[Full Text]
-
Mulcahy, H., O'Callaghan, J., O'Grady, E. P., Adams, C., O'Gara, F.
(2006). The Posttranscriptional Regulator RsmA Plays a Role in the Interaction between Pseudomonas aeruginosa and Human Airway Epithelial Cells by Positively Regulating the Type III Secretion System.. Infect. Immun.
74: 3012-3015
[Abstract]
[Full Text]
-
Shaver, C. M., Hauser, A. R.
(2006). Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals. Microbiology
152: 143-152
[Abstract]
[Full Text]
-
Kim, J., Ahn, K., Min, S., Jia, J., Ha, U., Wu, D., Jin, S.
(2005). Factors triggering type III secretion in Pseudomonas aeruginosa. Microbiology
151: 3575-3587
[Abstract]
[Full Text]
-
Wu, W., Jin, S.
(2005). PtrB of Pseudomonas aeruginosa Suppresses the Type III Secretion System under the Stress of DNA Damage. J. Bacteriol.
187: 6058-6068
[Abstract]
[Full Text]
-
Kierbel, A., Gassama-Diagne, A., Mostov, K., Engel, J. N.
(2005). The Phosphoinositol-3-Kinase-Protein Kinase B/Akt Pathway Is Critical for Pseudomonas aeruginosa Strain PAK Internalization. Mol. Biol. Cell
16: 2577-2585
[Abstract]
[Full Text]
-
Ahn, K.-S., Ha, U., Jia, J., Wu, D., Jin, S.
(2004). The truA gene of Pseudomonas aeruginosa is required for the expression of type III secretory genes. Microbiology
150: 539-547
[Abstract]
[Full Text]
-
Cowell, B. A., Twining, S. S., Hobden, J. A., Kwong, M. S. F., Fleiszig, S. M. J.
(2003). Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of epithelial cells. Microbiology
149: 2291-2299
[Abstract]
[Full Text]
-
Ha, U.-H., Wang, Y., Jin, S.
(2003). DsbA of Pseudomonas aeruginosa Is Essential for Multiple Virulence Factors. Infect. Immun.
71: 1590-1595
[Abstract]
[Full Text]